A Phase II study of Gemcitabine and Bexarotene (GemBex) in the treatment of cutaneous T-cell lymphoma

Authors
Category Primary study
Registry of TrialsEU Clinical Trials Register
Year 2006
This article has no abstract
Epistemonikos ID: eed3258a0e6f1fa981f6c86683e2aa1bc9a352b6
First added on: Jan 21, 2025